v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jul. 28, 2012
Jul. 30, 2011
Operating Activities:    
Consolidated net income, including loss from the noncontrolling interests $ 307,408 $ 373,982
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 201,555 211,550
Amortization of intangibles 30,053 33,486
Stock-based compensation 63,130 81,470
Excess tax benefits from stock-based compensation arrangements (179) (942)
Deferred income tax expense 8,707 54,170
Other (4,363) 9,901
Changes in assets and liabilities:    
Decrease in receivables 143,992 58,957
Increase in merchandise inventories (222,872) (276,649)
Increase in prepaid expenses and other assets (104,641) (38,399)
Increase in accounts payable 41,570 45,794
Decrease in accrued expenses and other liabilities (216,573) (264,790)
Increase in other long-term obligations 8,993 13,634
Net cash provided by operating activities 256,780 302,164
Investing Activities:    
Acquisition of property and equipment (126,220) (164,149)
Net cash used in investing activities (126,220) (164,149)
Financing Activities:    
Proceeds from issuance of Commercial Paper, net of repayments 49,998 254,926
Proceeds from the exercise of stock options 24,259 31,559
Proceeds from borrowings 47,243 118,174
Payments on borrowings (75,083) (698,631)
Purchase of noncontrolling interest (4,649) 0
Cash dividends paid (148,545) (140,643)
Excess tax benefits from stock-based compensation arrangements 179 942
Purchase of treasury stock, net (271,993) (365,203)
Net cash used in financing activities (378,591) (798,876)
Effect of exchange rate changes on cash and cash equivalents (31,452) 22,728
Net decrease in cash and cash equivalents (279,483) (638,133)
Cash and cash equivalents at beginning of period 1,264,149 1,461,257
Cash and cash equivalents at end of period $ 984,666 $ 823,124